omniture
logo
Search
IMMUNEONCIA THERAPEUTICS
Media Room

Latest News

rss

ImmuneOncia and 3D Medicines Signed Exclusive License Agreement to Develop, Manufacture and Commercialize IMC-002 in Greater China

* 3D Medicines to Lead the Manufacture, Clinical Development and Commercialization of IMC-002 for...

2021-03-31 09:00 2080